Increased FGFR3 expression enhanced the recurrence risk (hazard ratio 4.72, p = 0.029), while high FGFR4 expression was associated with lymph node metastasis (p = 0.036). Here, FGFR3 is linked to metastatic malignant neoplasm in the lymph nodes.